{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=21840&ordering=-accession","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=21800&ordering=-accession","results":[{"accession":"CLO:0021188","name":"ND07599 cell","definition":"[' EPILEPSY']","term_type":"cell line"},{"accession":"CLO:0021187","name":"ND07583 cell","definition":"[' TRANSIENT ISCHEMIC ATTACK']","term_type":"cell line"},{"accession":"CLO:0021186","name":"ND07582 cell","definition":"[' ISCHEMIC STROKE']","term_type":"cell line"},{"accession":"CLO:0021185","name":"GM11604 cell","definition":"[' NEURAMINIDASE DEFICIENCY']","term_type":"cell line"},{"accession":"CLO:0021184","name":"GM11605 cell","definition":"[' FAMILIAL OPTIC ATROPHY; TYPE UNKNOWN; LEBER-LIKE OPTIC ATROPHY COMPLEX I, SUBUNIT ND1; MTND1']","term_type":"cell line"},{"accession":"CLO:0021183","name":"GM11610 cell","definition":"[' MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1']","term_type":"cell line"},{"accession":"CLO:0021182","name":"GM11611 cell","definition":"[' MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1']","term_type":"cell line"},{"accession":"CLO:0021181","name":"GM11612 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD']","term_type":"cell line"},{"accession":"CLO:0021180","name":"GM11613 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD']","term_type":"cell line"},{"accession":"CLO:0021179","name":"GM11614 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD']","term_type":"cell line"},{"accession":"CLO:0021178","name":"GM11615 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD']","term_type":"cell line"},{"accession":"CLO:0021177","name":"GM11616 cell","definition":"[' MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1']","term_type":"cell line"},{"accession":"CLO:0021176","name":"GM11617 cell","definition":"[' MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1']","term_type":"cell line"},{"accession":"CLO:0021175","name":"ND07478 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0021174","name":"ND07489 cell","definition":"[' ALS PANEL CAUCASIAN FROM THE UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS']","term_type":"cell line"},{"accession":"CLO:0021173","name":"ND07508 cell","definition":"[' ALS PANEL CAUCASIAN FROM THE UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS']","term_type":"cell line"},{"accession":"CLO:0021172","name":"ND07509 cell","definition":"[' ISCHEMIC STROKE']","term_type":"cell line"},{"accession":"CLO:0021171","name":"ND07510 cell","definition":"[' ISCHEMIC STROKE']","term_type":"cell line"},{"accession":"CLO:0021170","name":"ND07511 cell","definition":"[\" POPULATION/CONVENIENCE CONTROL DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS\"]","term_type":"cell line"},{"accession":"CLO:0021169","name":"ND07512 cell","definition":"[\" POPULATION/CONVENIENCE CONTROL DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS\"]","term_type":"cell line"}]}